This apparent mutual exclusivity between NCOR1 mutations and LATS1 downregulation suggests that NCOR1 inactivation and decreased LATS1 expression may have a redundant impact on breast cancer, in agreement with their proposed shared mechanism of action. The gene discussed is LATS1; the disease is breast carcinoma.